Exchange: OTC·Updated 08:04 AM EDT

AROAF Aroa Biosurgery Limited

$0.52
$0.1041
(20.02%)
Pre-Market
Prev Close $0.52
EarningsNov 24
Mkt Cap$179.65M
Vol1,036.00

About AROAF

Aroa Biosurgery Ltd. engages in the development, manufacturing, and marketing of soft tissue repair products. It focuses on healing for complex wounds, and soft tissue reconstruction procedures including abdominal wall reconstruction, breast reconstruction, and reconstructive surgery for trauma, limb salvage, and tumor resections. The company was founded by Brian Roderick Ward in 2008 and is headquartered in Mangere, New Zealand.
50

Neutral Sentiment

How do you feel about AROAF?

Advertisement|Remove ads.